Quantum Technology: The Second Quantum Revolution

We are currently in the midst of a second quantum revolution. The first quantum revolution gave us new rules that govern physical reality. The second quantum revolution will take these rules and use them to develop new technologies. In this review we discuss the principles upon which quantum technology is based and the tools required to develop it. We discuss a number of examples of research programs that could deliver quantum technologies in coming decades including; quantum information technology, quantum electromechanical systems, coherent quantum electronics, quantum optics and coherent matter technology.Comment: 24 pages and 6 figure

New Challenges For Wind Shock Models: The Chandra Spectrum Of The Hot Star Delta Orionis

The Chandra spectrum of delta Ori A shows emission lines from hydrogen- and helium-like states of Si, Mg, Ne, and O, along with N VII Lyalpha and lines from ions in the range Fe XVII-Fe XXI In contrast to the broad lines seen in zeta Pup and zeta Ori (850 +/- 40 and 1000 +/- 240 km s(-1) half-width at half-maximum [HWHM], respectively), these lines are broadened to only 430 +/- 60 km s(-1) HWHM. This is much lower than the measured wind terminal velocity of 2000 km s(-1). The forbidden, intercombination, and resonance (fir) lines from He-like ions indicate that the majority of the X-ray line emission does not originate at the base of the wind, in agreement with the standard wind shock models for these objects. However, in that model the X-ray emission is distributed throughout an expanding, X-ray-absorbing wind, and it is therefore surprising that the emission lines appear relatively narrow, unshifted, and symmetric. We compare the observed line profiles to recent detailed models for X-ray line pro le generation in hot stars, but none of them offers a fully satisfactory explanation for the observed line profiles

Monopole supersymmetries and the Biedenharn operator

The hidden supersymmetry of the monopole found by De Jonghe et al. is generalized to a spin \2 particle in the combined field of a Dirac monopole plus a $\lambda^2/r^2$ potential [considered before by D'Hoker and Vinet], and related to the operator introduced by Biedenharn a long time ago in solving the Dirac-Coulomb problem. Explicit solutions are obtained by diagonalizing the Biedenharn operato

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

Objective To examine whether statins can reduce the risk of atrial fibrillation. Design Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies. Data sources Medline, Embase, and Cochrane's CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators. Study selection Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months' follow-up. Results In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39% (odds ratio 0.61, 95% confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99). Conclusions The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials

High Resolution X-ray Spectra of the Brightest OB Stars in the Cygnus OB2 Association

The Cygnus OB2 Association contains some of the most luminous OB stars in our Galaxy, the brightest of which are also among the most luminous in X-rays. We have obtained a Chandra High Energy Transmission Grating Spectrometer (HETGS) observation centered on Cyg OB2 No. 8a, the most luminous X-ray source in the Association. Although our analysis will focus on the X-ray properties of Cyg OB2 No. 8a, we also present limited analyses of three other OB stars (Cyg OB2 Nos. 5, 9, and 12). Applying standard diagnostic techniques as used in previous studies of early-type stars, we find that the X-ray properties of Cyg OB2 No. 8a are very similar to those of other OB stars that have been observed using high-resolution X-ray spectroscopy. From analyses of the He-like ion "fir" emission lines, we derive radial distances of the He-like line emission sources and find these fir-inferred radii are consistent with their corresponding X-ray continuum optical depth unity radii. Contrary to other O-star results, the emission lines of Cyg OB2 No. 8a show a large range in line centroid shifts (roughly -800 to +250 km/s). We discuss the implications of our results in light of the fact that Cyg OB2 No. 8a is a member of a rather tight stellar cluster, and shocks could arise at interfaces with the winds of these other stars.Comment: 36 pages (including 4 tables and 12 figures). LaTeX. Submitted to Ap

A Holstein-Primakoff and a Dyson realization for the quantum algebra Uq[sl(n+1)]U_q[sl(n+1)]

The known Holstein-Primakoff and Dyson realizations of the Lie algebra $sl(n+1), n=1,2,...$ in terms of Bose operators (Okubo S 1975 J. Math. Phys. 16 528) are generalized to the class of the quantum algebras $U_q[sl(n+1)]$ for any $n$. It is shown how the elements of $U_q[sl(n+1)]$ can be expressed via $n$ pairs of Bose creation and annihilation operators.Comment: 5 pages, Te

The incidence and risk factors for new onset atrial fibrillation in the PROSPER study

Aims Atrial fibrillation/flutter (AF) is the most common arrhythmia in older people. It associates with reduced exercise capacity, increased risk of stroke, and mortality. We aimed to determine retrospectively whether pravastatin reduces the incidence of AF and whether any electrocardiographic measures or clinical conditions might be risk factors for its development. Methods and results The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) was a randomized, double-blind controlled trial that recruited 5804 individuals aged 70-82 years with a history of, or risk factors for, vascular disease. A total of 2891 were allocated to pravastatin and 2913 to placebo; mean follow-up was 3.2 years. Electrocardiograms (ECGs), which were recorded at baseline, annually thereafter, and at run-out, were processed by computer and reviewed manually. In all, 264 of 2912 (9.1%) of the placebo group and 283 of 2888 (9.8%) of the pravastatin-treated group developed AF [hazard ratio 1.08 (0.92,1.28), P = 0.35)]. Multivariate analysis showed that PR and QTc intervals, age, left ventricular hypertrophy, and ST-T abnormalities were related to development of AF after adjustment for many variables including alcohol consumption, which itself was univariately predictive of developing AF. Previous myocardial infarction on the ECG was not a risk factor. A history of vascular disease was strongly linked with developing AF but not diabetes and hypertension. Conclusion Pravastatin does not reduce the incidence of AF in older people at risk of vascular disease, at least in the short-medium term. Risk factors for AF include older age, prolongation of PR or QTc intervals, left ventricular hypertrophy, and ST-T abnormalities on the EC